ASX - By Stock
|
NTI |
Re:
Ann: Commencement of Phase II/III ASD Clinical Trial
|
|
All4Info
|
9 |
3.3K |
0 |
04/01/23 |
04/01/23 |
ASX - By Stock
|
9
|
3.3K
|
0
|
|
ASX - By Stock
|
NHE |
Re:
Ann: 2022 Operational Review & 2023 Forward Plans
|
|
All4Info
|
24 |
13K |
1 |
20/12/22 |
20/12/22 |
ASX - By Stock
|
24
|
13K
|
1
|
|
Charts
|
NTI |
Re:
Chart - NTI
|
|
All4Info
|
139 |
55K |
3 |
13/12/22 |
13/12/22 |
Charts
|
139
|
55K
|
3
|
|
Charts
|
NTI |
Re:
Chart - NTI
|
|
All4Info
|
139 |
55K |
0 |
12/12/22 |
12/12/22 |
Charts
|
139
|
55K
|
0
|
|
ASX - By Stock
|
LRK |
Re:
Ann: Lark Distilling Co. Appoints CEO
|
|
All4Info
|
13 |
10K |
2 |
28/11/22 |
28/11/22 |
ASX - By Stock
|
13
|
10K
|
2
|
|
ASX - By Stock
|
LRK |
Re:
Ann: AGM Presentation
|
|
All4Info
|
1 |
1.0K |
8 |
22/11/22 |
22/11/22 |
ASX - By Stock
|
1
|
1.0K
|
8
|
|
ASX - By Stock
|
NYR |
Re:
Ann: AGM Presentation by James Bonnar CEO
|
|
All4Info
|
9 |
6.0K |
12 |
22/11/22 |
22/11/22 |
ASX - By Stock
|
9
|
6.0K
|
12
|
|
ASX - By Stock
|
NTI |
Re:
Ann: NTI Receives HREC/TGA Approval for Phase II/III ASD Trial
|
|
All4Info
|
7 |
2.2K |
0 |
18/11/22 |
18/11/22 |
ASX - By Stock
|
7
|
2.2K
|
0
|
|
ASX - By Stock
|
NTI |
Re:
Ann: NTI Receives HREC/TGA Approval for Phase II/III ASD Trial
|
|
All4Info
|
7 |
2.2K |
0 |
18/11/22 |
18/11/22 |
ASX - By Stock
|
7
|
2.2K
|
0
|
|
ASX - By Stock
|
NTI |
Re:
Ann: NTI Receives HREC/TGA Approval for Phase II/III ASD Trial
|
|
All4Info
|
7 |
2.2K |
0 |
18/11/22 |
18/11/22 |
ASX - By Stock
|
7
|
2.2K
|
0
|
|
ASX - By Stock
|
NHE |
Re:
Ann: Investor Presentation
|
|
All4Info
|
1 |
1.2K |
7 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
1
|
1.2K
|
7
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Neurotech Completes $9.0M Placement
|
|
All4Info
|
44 |
14K |
0 |
11/11/22 |
11/11/22 |
ASX - By Stock
|
44
|
14K
|
0
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Neurotech Completes $9.0M Placement
|
|
All4Info
|
44 |
14K |
3 |
11/11/22 |
11/11/22 |
ASX - By Stock
|
44
|
14K
|
3
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Neurotech Completes $9.0M Placement
|
|
All4Info
|
44 |
14K |
2 |
08/11/22 |
08/11/22 |
ASX - By Stock
|
44
|
14K
|
2
|
|
ASX - By Stock
|
NTI |
Re:
The NDIS -- Autism and how we offer a solution
|
|
All4Info
|
4 |
2.6K |
0 |
08/11/22 |
08/11/22 |
ASX - By Stock
|
4
|
2.6K
|
0
|
|
ASX - By Stock
|
JAL |
Re:
Ann: Cleansing Notice Tranche 1 Placement
|
|
All4Info
|
12 |
4.9K |
2 |
08/11/22 |
08/11/22 |
ASX - By Stock
|
12
|
4.9K
|
2
|
|
ASX - By Stock
|
JAL |
Re:
Ann: Cleansing Notice Tranche 1 Placement
|
|
All4Info
|
12 |
4.9K |
0 |
07/11/22 |
07/11/22 |
ASX - By Stock
|
12
|
4.9K
|
0
|
|
ASX - By Stock
|
JAL |
Re:
Ann: Cleansing Notice Tranche 1 Placement
|
|
All4Info
|
12 |
4.9K |
0 |
07/11/22 |
07/11/22 |
ASX - By Stock
|
12
|
4.9K
|
0
|
|
ASX - By Stock
|
JAL |
Re:
Ann: Cleansing Notice Tranche 1 Placement
|
|
All4Info
|
12 |
4.9K |
1 |
07/11/22 |
07/11/22 |
ASX - By Stock
|
12
|
4.9K
|
1
|
|
ASX - By Stock
|
LRK |
Re:
Ann: Lark Distilling Co. Appoints CEO
|
|
All4Info
|
13 |
10K |
1 |
04/11/22 |
04/11/22 |
ASX - By Stock
|
13
|
10K
|
1
|
|
ASX - By Stock
|
LRK |
Re:
Ann: Lark Distilling Co. Appoints CEO
|
|
All4Info
|
13 |
10K |
7 |
04/11/22 |
04/11/22 |
ASX - By Stock
|
13
|
10K
|
7
|
|
ASX - By Stock
|
LRK |
Re:
Ann: September 2022 Quarterly Update and Appendix 4C
|
|
All4Info
|
8 |
3.8K |
0 |
04/11/22 |
04/11/22 |
ASX - By Stock
|
8
|
3.8K
|
0
|
|
ASX - By Stock
|
LRK |
Re:
Ann: Lark Distilling Co. Appoints CEO
|
|
All4Info
|
13 |
10K |
13 |
04/11/22 |
04/11/22 |
ASX - By Stock
|
13
|
10K
|
13
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Neurotech Completes $9.0M Placement
|
|
All4Info
|
44 |
14K |
3 |
03/11/22 |
03/11/22 |
ASX - By Stock
|
44
|
14K
|
3
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Neurotech Completes $9.0M Placement
|
|
All4Info
|
44 |
14K |
5 |
03/11/22 |
03/11/22 |
ASX - By Stock
|
44
|
14K
|
5
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
All4Info
|
48 |
12K |
4 |
01/11/22 |
01/11/22 |
ASX - By Stock
|
48
|
12K
|
4
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
All4Info
|
48 |
12K |
25 |
01/11/22 |
01/11/22 |
ASX - By Stock
|
48
|
12K
|
25
|
|
ASX - By Stock
|
LRK |
Re:
Ann: September 2022 Quarterly Update and Appendix 4C
|
|
All4Info
|
8 |
3.8K |
4 |
01/11/22 |
01/11/22 |
ASX - By Stock
|
8
|
3.8K
|
4
|
|
ASX - By Stock
|
LRK |
Re:
Ann: September 2022 Quarterly Update and Appendix 4C
|
|
All4Info
|
8 |
3.8K |
5 |
31/10/22 |
31/10/22 |
ASX - By Stock
|
8
|
3.8K
|
5
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Neurotech Completes $9.0M Placement
|
|
All4Info
|
44 |
14K |
2 |
30/10/22 |
30/10/22 |
ASX - By Stock
|
44
|
14K
|
2
|
|
ASX - By Stock
|
NHE |
Re:
Ann: Noble Helium to Raise $6.1M via Oversubscribed Placement
|
|
All4Info
|
5 |
2.6K |
0 |
28/10/22 |
28/10/22 |
ASX - By Stock
|
5
|
2.6K
|
0
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Neurotech Completes $9.0M Placement
|
|
All4Info
|
44 |
14K |
4 |
28/10/22 |
28/10/22 |
ASX - By Stock
|
44
|
14K
|
4
|
|
ASX - By Stock
|
LOM |
Re:
Ann: Quarterly Activities Report
|
|
All4Info
|
62 |
14K |
11 |
28/10/22 |
28/10/22 |
ASX - By Stock
|
62
|
14K
|
11
|
|
ASX - By Stock
|
LRK |
Re:
Ann: Quarterly Results Webinar
|
|
All4Info
|
2 |
969 |
6 |
28/10/22 |
28/10/22 |
ASX - By Stock
|
2
|
969
|
6
|
|
ASX - By Stock
|
LRK |
Re:
Ann: Annual Report to Shareholders
|
|
All4Info
|
43 |
17K |
1 |
28/10/22 |
28/10/22 |
ASX - By Stock
|
43
|
17K
|
1
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Neurotech Completes $9.0M Placement
|
|
All4Info
|
44 |
14K |
2 |
28/10/22 |
28/10/22 |
ASX - By Stock
|
44
|
14K
|
2
|
|
ASX - By Stock
|
NTI |
Re:
Ann: 20 Week Data Shows Significant Improvement For ASD Children
|
|
All4Info
|
10 |
3.5K |
5 |
28/10/22 |
28/10/22 |
ASX - By Stock
|
10
|
3.5K
|
5
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Neurotech Completes $9.0M Placement
|
|
All4Info
|
44 |
14K |
2 |
28/10/22 |
28/10/22 |
ASX - By Stock
|
44
|
14K
|
2
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Neurotech Completes $9.0M Placement
|
|
All4Info
|
44 |
14K |
4 |
28/10/22 |
28/10/22 |
ASX - By Stock
|
44
|
14K
|
4
|
|
ASX - By Stock
|
NTI |
Re:
Ann: 20 Week Data Shows Significant Improvement For ASD Children
|
|
All4Info
|
10 |
3.5K |
1 |
28/10/22 |
28/10/22 |
ASX - By Stock
|
10
|
3.5K
|
1
|
|
ASX - By Stock
|
IVZ |
Re:
IVZ Share Price
|
|
All4Info
|
21K |
7.2M |
8 |
25/10/22 |
25/10/22 |
ASX - By Stock
|
21K
|
7.2M
|
8
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Trading Halt
|
|
All4Info
|
5 |
2.1K |
4 |
25/10/22 |
25/10/22 |
ASX - By Stock
|
5
|
2.1K
|
4
|
|
ASX - By Stock
|
LRK |
Re:
True volume of whisky under maturation
|
|
All4Info
|
27 |
11K |
3 |
24/10/22 |
24/10/22 |
ASX - By Stock
|
27
|
11K
|
3
|
|
ASX - By Stock
|
LRK |
Re:
True volume of whisky under maturation
|
|
All4Info
|
27 |
11K |
6 |
21/10/22 |
21/10/22 |
ASX - By Stock
|
27
|
11K
|
6
|
|
ASX - By Stock
|
NTI |
Re:
NTI Chart
|
|
All4Info
|
283 |
117K |
1 |
21/10/22 |
21/10/22 |
ASX - By Stock
|
283
|
117K
|
1
|
|
ASX - By Stock
|
NTI |
Re:
NTI Chart
|
|
All4Info
|
283 |
117K |
4 |
20/10/22 |
20/10/22 |
ASX - By Stock
|
283
|
117K
|
4
|
|
ASX - By Stock
|
IVZ |
Re:
IVZ Share Price
|
|
All4Info
|
21K |
7.2M |
6 |
18/10/22 |
18/10/22 |
ASX - By Stock
|
21K
|
7.2M
|
6
|
|
ASX - By Stock
|
NTI |
Re:
Ann: New Phase I/II Clinical Trial in Children with PANDAS/PANS
|
|
All4Info
|
5 |
1.8K |
2 |
18/10/22 |
18/10/22 |
ASX - By Stock
|
5
|
1.8K
|
2
|
|
ASX - By Stock
|
LRK |
Re:
True volume of whisky under maturation
|
|
All4Info
|
27 |
11K |
5 |
18/10/22 |
18/10/22 |
ASX - By Stock
|
27
|
11K
|
5
|
|
ASX - By Stock
|
NTI |
Re:
Ann: New Phase I/II Clinical Trial in Children with PANDAS/PANS
|
|
All4Info
|
5 |
1.8K |
2 |
17/10/22 |
17/10/22 |
ASX - By Stock
|
5
|
1.8K
|
2
|
|